Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Fibromyalgia Treatment Market, by Drug Class
1.4.2 North America Fibromyalgia Treatment Market, by Distribution Channel
1.4.3 North America Fibromyalgia Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Fibromyalgia Treatment Market by Drug Class
3.1 North America Anticonvulsants Market by Country
3.2 North America Antidepressants Market by Country
3.3 North America Muscle Relaxants Market by Country
3.4 North America Others Market by Country
Chapter 4. North America Fibromyalgia Treatment Market by Distribution Channel
4.1 North America Drug stores & Retail Pharmacies Market by Country
4.2 North America Hospital Pharmacies Market by Country
4.3 North America Online Providers Market by Country
Chapter 5. North America Fibromyalgia Treatment Market by Country
5.1 US Fibromyalgia Treatment Market
5.1.1 US Fibromyalgia Treatment Market by Drug Class
5.1.2 US Fibromyalgia Treatment Market by Distribution Channel
5.2 Canada Fibromyalgia Treatment Market
5.2.1 Canada Fibromyalgia Treatment Market by Drug Class
5.2.2 Canada Fibromyalgia Treatment Market by Distribution Channel
5.3 Mexico Fibromyalgia Treatment Market
5.3.1 Mexico Fibromyalgia Treatment Market by Drug Class
5.3.2 Mexico Fibromyalgia Treatment Market by Distribution Channel
5.4 Rest of North America Fibromyalgia Treatment Market
5.4.1 Rest of North America Fibromyalgia Treatment Market by Drug Class
5.4.2 Rest of North America Fibromyalgia Treatment Market by Distribution Channel
Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.2 AbbVie, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Novartis AG
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Acquisition and Mergers:
6.4 Eli Lilly And Company
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.5 Amneal Pharmaceuticals, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.5.4 Research & Development Expenses
6.6 Teva Pharmaceutical Industries Ltd.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.7 Zydus Lifesciences Ltd.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Trials and Approvals:
6.8 Lupin Limited
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Recent strategies and developments:
6.8.3.1 Trials and Approvals:
6.9 Viatris, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental Analysis
6.9.4 Research & Development Expense
6.10. Sun Pharmaceutical Industries Ltd.
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expenses



List of Figures

FIG 1 Methodology for the research
FIG 2 North America Fibromyalgia Treatment Market share by Drug Class, 2022
FIG 3 North America Fibromyalgia Treatment Market share by Drug Class, 2030
FIG 4 North America Fibromyalgia Treatment Market by Drug Class, 2019 - 2030, USD Million
FIG 5 North America Fibromyalgia Treatment Market share by Distribution Channel, 2022
FIG 6 North America Fibromyalgia Treatment Market share by Distribution Channel, 2030
FIG 7 North America Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2030, USD Million
FIG 8 North America Fibromyalgia Treatment Market share by Country, 2022
FIG 9 North America Fibromyalgia Treatment Market share by Country, 2030
FIG 10 North America Fibromyalgia Treatment Market by Country, 2019 - 2030, USD Million
FIG 11 Swot analysis: Abbott laboratories

List of Tables

TABLE 1 North America Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 2 North America Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 3 North America Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 4 North America Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 5 North America Anticonvulsants Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Anticonvulsants Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Antidepressants Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Antidepressants Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Muscle Relaxants Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Muscle Relaxants Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 13 North America Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 14 North America Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 15 North America Drug stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Drug stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Fibromyalgia Treatment Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Fibromyalgia Treatment Market by Country, 2023 - 2030, USD Million
TABLE 23 US Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 24 US Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 25 US Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 26 US Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 27 US Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 28 US Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 29 Canada Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 30 Canada Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 31 Canada Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 32 Canada Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 33 Canada Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 Canada Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 35 Mexico Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 36 Mexico Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 37 Mexico Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 38 Mexico Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 39 Mexico Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 40 Mexico Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 41 Rest of North America Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 42 Rest of North America Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 43 Rest of North America Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 44 Rest of North America Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 45 Rest of North America Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 46 Rest of North America Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 47 Key Information – Abbott Laboratories
TABLE 48 Key information – AbbVie, Inc.
TABLE 49 Key Information – Novartis AG
TABLE 50 Key Information – Eli Lilly And Company
TABLE 51 Key Information – Amneal Pharmaceuticals, INc.
TABLE 52 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 53 Key Information – Zydus Lifesciences Ltd.
TABLE 54 Key Information – Lupin Limited
TABLE 55 key information – Viatris, Inc.
TABLE 56 Key Information – Sun Pharmaceutical Industries Ltd.